Effects of COX-2 inhibitors on ROS produced by Chlamydia pneumoniae-primed human promonocytic cells (THP-1).

MLA

Mouithys-Mickalad, Ange, et al. “Effects of COX-2 Inhibitors on ROS Produced by Chlamydia Pneumoniae-Primed Human Promonocytic Cells (THP-1).” Biochemical and Biophysical Research Communications, vol. 325, no. 4, Dec. 2004, pp. 1122–30. EBSCOhost, https://doi.org/10.1016/j.bbrc.2004.10.155.

APA

Mouithys-Mickalad, A., Deby-Dupont, G., Dogne, J.-M., de Leval, X., Kohnen, S., Navet, R., Sluse, F., Hoebeke, M., Pirotte, B., & Lamy, M. (2004). Effects of COX-2 inhibitors on ROS produced by Chlamydia pneumoniae-primed human promonocytic cells (THP-1). Biochemical and Biophysical Research Communications, 325(4), 1122–1130. https://doi.org/10.1016/j.bbrc.2004.10.155

Chicago

Mouithys-Mickalad, Ange, Ginette Deby-Dupont, Jean-Michel Dogne, Xavier de Leval, Stephan Kohnen, Rachel Navet, Francis Sluse, Maryse Hoebeke, Bernard Pirotte, and Maurice Lamy. 2004. “Effects of COX-2 Inhibitors on ROS Produced by Chlamydia Pneumoniae-Primed Human Promonocytic Cells (THP-1).” Biochemical and Biophysical Research Communications 325 (4): 1122–30. doi:10.1016/j.bbrc.2004.10.155.